1. A Discussion of Genotype/Phenotype Correlations in NF1
  2. FDA Approves Selumetinib as First Treatment for NF1 and a Discussion of MEK Inhibitor-Based Treatments for Plexiform Neurofibromas
  3. Considerations for Individuals with NF Regarding the Novel Coronavirus
  4. The Role of Precision Medicine in NF Diagnosis and Treatment
  5. Highlights from the 2019 NF Conference and ASHG Meeting, Re-Cap of NF Walk, UAB NF Clinic News, and Final Installment of a Review of the Pediatric NF Clinical Care Resource
  6. Upcoming NF Conference and a Review of the Pediatric NF Clinical Care Resource for Neurodevelopmental Problems and Skeletal Abnormalities
  7. UAB NF Symposium Family Day and a Review of Pediatric NF Clinical Care Guidelines for Malignancies and Neurologic Issues Related to NF1
  8. NF Clinic Update and a Review of Pediatric NF Clinical Care Guidelines for Optic Pathway Gliomas and Indications for Neuroimaging in Children with NF1
  9. A Discussion of Newly Published Pediatric NF Clinical Care Guidelines
  10. Approaches to Imaging in the Diagnosis and Management of NF
  11. Explanation of a New Method for Answering NF-Related Email Questions
  12. NF Clinic Adjustments and a Discussion of the Differences Between Schwannomas and Neurofibromas
  13. Multi-Year Research Grants Awarded to UAB Investigators Pursuing Genome-Guided Therapeutics
  14. A Re-Cap of the 2018 NF Conference in Paris
  15. Highlights of Visit with Australian NF Team and Advice for Locating an Experienced NF Program
  16. Upcoming NF Conference and a Final Review of the ACMG Clinical Practice Resource
  17. A Review of ACMG Clinical Practice Resource Related to Hypertension and Vasculopathy, Osteoporosis, and Cutaneous Neurofibromas
  18. A Discussion of ACMG Clinical Practice Resource Related to Tumors Associated with NF1
  19. Highlights of the NF Forum and a Discussion of Newly Published Clinical Care Guidelines for NF1
  20. Highlights of NF Symposium and a Discussion of the Frequency of NF Clinic Visits
  21. A Focus on Improving Our Patients’ Experience and the Relationship Between Atypical Neurofibromas and Malignant Peripheral Nerve Sheath Tumors
  22. New Role as UAB Medicine’s Chief Genomics Officer, Upcoming NF Family Day, and Newly Identified Mutation/Phenotype Correlation in NF
  23. A Re-Cap of the Year’s Endeavors and a Preview of Plans for 2018
  24. Highlights of American Society of Human Genetics Meeting, Alabama NF Walk, and a Discussion of Muscle Involvement in NF1
  25. Recognizing Problems That Require Further Evaluation in Children with NF1
  26. Department of Defense NF Research Program Grant Proposals and a Review of Pain in the Context of NF
  27. Highlights of the 2017 NF Conference, NF Clinical Trials Consortium Update, and Frequently Asked Questions about Clinical Trials
  28. Development of Genome-Guided Therapeutics for NF Based on Genetic Mutation Subsets
  29. Current and Future Research Initiatives for the Treatment of Cutaneous Neurofibromas
  30. Highlights of UAB Rare Disease Genomics Symposium and a Discussion of Visual Screening in Children with NF1
  31. Continued Benefits of NF Clinic Relocations and a Discussion of Headaches in Individuals with NF1
  32. Renewed Grant for the NF Clinical Trials Consortium and a Promising New Drug for the Treatment of NF1
  33. Highlights of a Successful Year and a Look Ahead to New Goals for 2017
  34. Successful Relocation of Adult and Pediatric NF Clinics and a Discussion of Increased Breast Cancer Risk in Women with NF1
  35. A Successful 3rd Annual Alabama NF Walk and a Discussion of Developmental Issues and Cognitive Function in NF1
  36. Highlights of NF Symposium, Plans for 3rd Annual NF Walk, Discussion of Mosaic NF1, and a Review of the NF Neurologic Exam
  37. Upcoming NF Symposium at Children’s Harbor, Applications of New Gene Editing Technology, and a Review of the NF Extremities Exam
  38. NF Clinic Genetics Counselor Receives Esteemed Scholars Award, Re-Cap of NF Forum, and What to Expect During an NF Genital Exam
  39. Upcoming NF Symposium, Enhanced Patient Exam Procedure, and a Review of the NF Abdominal Exam
  40. Sources of Variability in NF and What to Expect During an NF Chest Examination
  41. Re-Cap of Meetings in Washington, DC, for Renewed NF Research Funding and a Review of What to Expect During an NF Neck Exam
  42. New Discoveries in the UAB Medical Genomics Laboratory, Animal Model Progress, and NF-Related Features of the Head
  43. New Year’s Resolutions for the NF Program and Common Skin Issues Detected During an NF Clinic Visit
  44. Animal Model Research Update, Plans for Adult and Pediatric NF Clinics, and the Focus of Exams in an NF Clinic
  45. Successful 2nd Annual Alabama NF Walk and Update on Newly Formed NF Community Advisory Board
  46. Upcoming 2nd Annual Alabama NF Walk and Understanding the Role of NF Genetic Testing
  47. A Successful and Memorable NF Family Day and Plans for Future Dermal Neurofibroma Trials
  48. A New Specialist Joins the NF Clinic Team, Upcoming NF Symposium at UAB, and Understanding RAS Disorders and their Relationship to NF
  49. Understanding Possible Explanations for Isolated Features of NF
  50. Responding to E-mailed Questions from Patients and Reviewing Diagnostic Criteria for Café-Au-Lait Spots and Groin Freckling
  51. Measurement Technique for Dermal Neurofibromas Validated at UAB Expands Possibilities for Clinical Trials
  52. Birmingham Family Affected by NF Recognized at CTF BeNeFit II Gala in Detroit, and Frequently Asked Patient Questions Regarding NF Clinical Trials
  53. Highlights of NF Family Day and Encouraging Developments from an International NF Meeting
  54. Upcoming NF Family Day, Research Advances, and a Special Award for a Birmingham Family Affected by NF
  55. A Successful NF Walk, Two Key NF Conferences, and Rapid Research Progress
  56. A new website and Birmingham's first NF walk